No Data
No Data
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 MRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
Sunshine Biopharma Launches a New Generic Prescription Drug
US Manufacturing Index Rises To 43, Highest Since 2020
8-K: SUNSHINE BIOPHARMA REPORTS 2024 THIRD QUARTER RESULTS: YEAR-TO-DATE REVENUES UP 54%
Earnings Flash (SBFM) SUNSHINE BIOPHARMA Reports Q3 Revenue $8.4M
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%